Circadian rhythms, gut microbiome, and gestational diabetes are active...
Understanding beta cell function is key to understanding the pathophysiology of both type 1 and type 2 diabetes. The Islet Biology/Insulin Secretion theme at the 75th Scientific Sessions in Boston will...
View ArticleExperts to provide updates on several diabetes complications
Diabetes complications — hypoglycemia, neuropathy, ocular, macrovascular, cardiovascular, lower limb, kidney, and many others — are well known as direct causes of morbidity and mortality in both type 1...
View ArticleNew partnership between the NIH, pharma, and the ADA is designed to spur...
Jose C. Florez, MD, PhD In what is expected to be a major boost for the development of novel medications for type 2 diabetes, the National Institutes of Health (NIH) has launched a bold Accelerating...
View ArticleExperts will explore the future of beta cell replacement
Nicole A. Turgeon, MD Beta cell replacement is the future of type 1 diabetes treatment and could even help certain patients with type 2 diabetes. A pair of clinical sessions in the...
View ArticleSeveral sessions will highlight new developments in clinical diabetes and...
With a lineup of more than 30 sessions, the Clinical Diabetes/Therapeutics track is easily the most active theme area at the 75th Scientific Sessions. With topics ranging from new insulins to...
View ArticleClinical sessions will address behavioral medicine, nutrition, education, and...
Martha M. Funnell, MS, RN, CDE From evidence-based eating tips to the effective use of technology, practice tips for advanced practitioners, new tools to assess exercise, and proven strategies to...
View ArticleResearch continues to study role of inflammation and fat in type 2 diabetes
Jacqueline M. Stephens, PhD Three important sessions in the Insulin Action/Molecular Metabolism track at the 75th Scientific Sessions focus on the conflicting roles of inflammation in adipose tissue,...
View ArticleResearchers to report results from ELIXA and TECOS trials
Results from two major cardiovascular trials will be reported at the 75th Scientific Sessions. The two studies, ELIXA and TECOS, examine two different incretin drugs and both include heart failure as a...
View ArticleScientific Sessions will celebrate 75th anniversary in Boston
This year marks the 75th anniversary of the American Diabetes Association and its Scientific Sessions, the world’s foremost meeting on diabetes. The meeting will be held June 5-9, 2015, at the Boston...
View Article
More Pages to Explore .....